Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 72162-2317

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 72162-2317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1a (22bf08c2 615b 4b48 Af36 1b71a91459dc 01)

A line graph comparing baseline systolic blood pressure (SBP) in mmHg on the x-axis with percentage of patients achieving SBP below 140 mmHg on the y-axis. The graph shows multiple study lines labeled as Av. Study V, Irb. Study V, HCTZ Study V, Av. Study VI, and Irb. Study VI, depicting treatment effects on lowering SBP.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1b (22bf08c2 615b 4b48 Af36 1b71a91459dc 02)

A line graph showing the relationship between baseline systolic blood pressure (SBP) in mmHg on the x-axis and the percentage of subjects with SBP ≤ 130 mmHg on the y-axis. The graph includes multiple curves representing different study groups related to Irbesartan and Hydrochlorothiazide, including average studies and separate studies for Irbesartan, hydrochlorothiazide, and their combinations.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2a (22bf08c2 615b 4b48 Af36 1b71a91459dc 03)

A line graph depicting the percentage change in diastolic blood pressure (DBP) from baseline across two studies (Study V and Study VI) for three groups: Average Study, Irbesartan (Irb), and Hydrochlorothiazide (HCTZ). The x-axis represents baseline DBP in mmHg, while the y-axis shows percent DBP change.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2b (22bf08c2 615b 4b48 Af36 1b71a91459dc 04)

A line graph showing the percent reduction in diastolic blood pressure (DBP) below 80 mmHg plotted against baseline DBP (mmHg). The graph includes curves for average and individual studies labeled as Study V and Study VI, tracking effects of irbesartan and hydrochlorothiazide.*

FDA Label Image

Chemical Structure Irbesartan (22bf08c2 615b 4b48 Af36 1b71a91459dc 05)

Chemical structure of the active ingredient Irbesartan and Hydrochlorothiazide, depicted as a two-dimensional molecular diagram showing the arrangement of atoms and bonds in the compound.*

FDA Label Image

Chemical Structure Hydrochlorothiazide (22bf08c2 615b 4b48 Af36 1b71a91459dc 06)

Chemical structure of Irbesartan and Hydrochlorothiazide, showing molecular arrangement with sulfonamide and chlorinated benzene ring components.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 3 (22bf08c2 615b 4b48 Af36 1b71a91459dc 07)

A graph charting the placebo-subtracted reduction in trough SeSBP relative to Irbesartan dose in mg/day. The x-axis shows Irbesartan dose (150 to 900 mg/day), and the y-axis shows blood pressure reduction in mmHg, with data points and a fitted curve. The title references an integrated analysis of the effect.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 4 (22bf08c2 615b 4b48 Af36 1b71a91459dc 08)

A scatter plot with an overlaid curve depicting the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeDBP (mmHg) on the y-axis. The plot shows increasing reduction in SeDBP with higher doses of Irbesartan, leveling off at higher doses.*

FDA Label Image

Label (Lbl721622317)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP, containing 150 mg of Irbesartan and 12.5 mg of Hydrochlorothiazide per film-coated tablet. Packaged as 30 tablets, relabeled by Bryant Ranch Prepack and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. Storage instructions and a link for pharmacist dosage information are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.